Cancer is the name of a group of diseases characterised by the autonomous, uncontrolled growth and proliferation of cells within the body. These cells have the potential to spread from the primary tumour to other parts of the body and develop secondary tumours (known as metastatic tumours) via a process known as metastasis. Most cancers have the ability to metastasise, which results in the majority of cancer related deaths.
In the early stages of the disease, there may be no or relatively few noticeable symptoms, however, as the disease progresses and the cancer begins to spread, symptoms can be both varied and devastating. It is estimated that genetic mutations, caused by environmental and lifestyle factors (including: tobacco, diet, obesity, infections, and radiation), account for ninety to ninety five percent of all cancer cases, while the remaining five to ten percent of cases are thought to be hereditary.
Treating cancer can be both difficult and complex with many treatment options available. The main options include: surgery, chemotherapy, radiation therapy, hormonal therapy and, if curative treatment is not possible, palliative care. The exact treatments used can depend on the type, location, and grade of the cancer and also account for the patient's health and treatment preferences.
We offer a comprehensive portfolio of antibodies, proteins, and assays for cancer research that exhibit high specificity, activity, performance, and reproducibility in a range of techniques, including: Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), and ELISA. These tools are commonly used to study apoptosis, cell growth, cell signaling, invasion / metatastasis, oncoproteins, and metabolism.